Noa G Holtzman

13PUBLICATIONS
50CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesHaematologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Baricitinib for refractory chronic graft-versus-host disease: results of a phase 1/2 study.

|Jul 24, 2025
CD123-targeting immunotherapeutic approaches in acute myeloid leukaemia.

Alexandra Dreyzin, Noa G Holtzman, Challice L Bonifant

|May 01, 2025
Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study.

Rubina Sharma, Noa G Holtzman, Iskra Pusic

|Apr 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention.

Noa G Holtzman, Lauren M Curtis, Rachel B Salit

|May 06, 2022
The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.

Yifan Pang, Ananth V Charya, Michael B Keller

|Oct 02, 2021
The clinical landscape of chronic graft-versus-host disease management in 2021.

Noa G Holtzman, Steven Z Pavletic

Pageof 3

Frequent Collaborators

3 joint publications

Filip Pirsl

3 joint publications

Eduard Schulz

2 joint publications

Vu H Duong

2 joint publications

Jacqueline Wiesehan Mays